6 October, 2016
Bruce Dave (CEO ARANZ Medical) receiving WITSA award from Santiago Gutierrez (chairman of WITSA) and Yvonne Chiu (Chairman of the Information Service Industry of the R.O.C. (Taiwan))
BRASILIA, Brazil, October 5, 2016 – ARANZ Medical, a specialist in 3D scanning and informatics solutions for the healthcare sector, has been named the Private Sector Excellence Award winner at the World Information Technology and Services Alliance (WITSA) Global ICT Excellence Awards 2016. The award was presented by WITSA, the recognized leading voice of the global ICT industry, at the World Congress Gala Dinner in Brasilia last night, part of the 2016 World Congress on Information Technology (WCIT).
ARANZ Medical’s key innovations transform a number of crucial clinical assessment practices, improve quality of care, and make delivery of care more cost-effective. The innovations include: Silhouette, an FDA-approved advanced wound surveillance system; and FastSCAN which enables the custom-fit of orthotics and prosthetics.
Dr Bruce Davey, CEO of ARANZ Medical says, “We’re very proud to have our achievement in using ICT to transform healthcare and impact peoples’ lives recognised in this way. We have an incredibly talented and dedicated team who live and breathe our mission to help people heal people. We do this by developing highly sophisticated, yet easy to use technology that transforms some of the most primitive processes in healthcare.”
WITSA Chairman Santiago Gutierrez was impressed by the candidates from around the world for the 2016 WITSA Global ICT Excellence Awards and congratulated ARANZ Medical CEO Bruce Davey for the company being the top pick in the Private Sector IT Excellence category.
The WITSA Global ICT Excellence Award Ceremony is held once every two years in conjunction with the World Congress on Information Technology to recognize select organizations whose use of IT has exhibited exceptional achievement in using ICT to benefit societies, governments, organizations and individuals.
ARANZ Medical’s solutions are making a difference in over 35 countries across the globe in a range of clinical practice and research settings: from Africa, where the World Health Organization is using Silhouette in rural Africa as part of an important study of Buruli ulcer, one of the world’s most neglected tropical diseases; to some of the biggest healthcare providers in the United States and United Kingdom.
Dr Davey says, “Our technology equips researchers and clinicians with important new knowledge which empowers them to improve the lives of millions of people worldwide, including high risk groups such as diabetes sufferers and the elderly.”
Demand for ARANZ Medical’s solutions is growing rapidly due to the increased prevalence of diseases like diabetes, an ageing population, more accountable healthcare and the emerging telehealth trend.
Over 40 million people around the world suffer from chronic wounds such as pressure ulcers, venous ulcers and diabetic ulcers and this number is expected to grow to more than 60 million by 2017. Wounds can lead to significant pain, sepsis, re-admissions, social isolation, amputations, and death. Amputation rates are also increasing, with some experts estimating that every 30 seconds a lower limb is lost to diabetes somewhere in the world.
WITSA award categories include: Private Sector Excellence, Public Sector Excellence, Mobile Excellence, Digital Opportunity and Sustainable Growth. In addition, a special Chairman’s Award is presented to a nominee from the entire pool of candidates from all five categories.
Nominations for the awards are made by WITSA’s member organisations from over 80 countries who represent more than 90 percent of the world ICT market. ARANZ Medical was nominated for the Private Sector Excellence Award by NZTech.
Dr Davey says, “We’d also like to acknowledge the work of WITSA as well as the outstanding support we’ve received from key organisations including New Zealand Trade & Enterprise, Callaghan Innovation and NZTech as we’ve worked to become a recognised global ICT innovator in the healthcare industry.”
